Myomo (MYO) EPS (Weighted Average and Diluted) (2021 - 2025)
Myomo's EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.09 for Q3 2025.
- For Q3 2025, EPS (Weighted Average and Diluted) fell 200.0% year-over-year to -$0.09; the TTM value through Sep 2025 reached -$0.29, down 26.09%, while the annual FY2024 figure was -$0.16, 42.86% up from the prior year.
- EPS (Weighted Average and Diluted) reached -$0.09 in Q3 2025 per MYO's latest filing, up from -$0.12 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q2 2024 to a low of -$0.58 in Q4 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.2, with a median of -$0.11 recorded in 2023.
- Peak YoY movement for EPS (Weighted Average and Diluted): surged 90.48% in 2023, then tumbled 300.0% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.58 in 2021, then soared by 51.6% to -$0.28 in 2022, then surged by 75.0% to -$0.07 in 2023, then skyrocketed by 52.07% to -$0.03 in 2024, then crashed by 168.27% to -$0.09 in 2025.
- Per Business Quant, the three most recent readings for MYO's EPS (Weighted Average and Diluted) are -$0.09 (Q3 2025), -$0.12 (Q2 2025), and -$0.08 (Q1 2025).